Home > > > > > Report Detail

Global (United States, European Union and China) Antipsychotic Drugs Market Research Report 2019-2025

Publisher Name :
Date: 21-Aug-2019
No. of pages: 119
Inquire Before Buying

Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.

During 2016, the second-generation antipsychotic drugs segment dominated the antipsychotic drugs market with the highest market shares. These drugs are preferred over first-generation antipsychotic drugs because they involve lesser side effects and are highly efficient in the treatment of various mental disorders. The adoption of these drugs is high because they reduce EPSE, controls symptoms, and maintains the normal levels of prolactin. This segment yields a high prescription value that in turn, will drive growth in the segment during the forecasted period.

In 2019, the market size of Antipsychotic Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antipsychotic Drugs.

This report studies the global market size of Antipsychotic Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Antipsychotic Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- AstraZeneca

- Eli Lilly

- GlaxoSmithKline

- Johnson & Johnson

- Actavis Generics

- Alkermes

- Bristol-Myers Squibb

Market Segment by Product Type

- First Antipsychotic Drugs

- Second Antipsychotic Drugs

- Third Antipsychotic Drugs

Market Segment by Application

- Schizophrenia

- Bipolar Disorder

- Unipolar Depression

- Dementia

- Others

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Antipsychotic Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Antipsychotic Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Antipsychotic Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Antipsychotic Drugs Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antipsychotic Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 First Antipsychotic Drugs
1.3.3 Second Antipsychotic Drugs
1.3.4 Third Antipsychotic Drugs
1.4 Market Segment by Application
1.4.1 Global Antipsychotic Drugs Market Share by Application (2019-2025)
1.4.2 Schizophrenia
1.4.3 Bipolar Disorder
1.4.4 Unipolar Depression
1.4.5 Dementia
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antipsychotic Drugs Market Size
2.1.1 Global Antipsychotic Drugs Revenue 2014-2025
2.1.2 Global Antipsychotic Drugs Sales 2014-2025
2.2 Antipsychotic Drugs Growth Rate by Regions
2.2.1 Global Antipsychotic Drugs Sales by Regions 2014-2019
2.2.2 Global Antipsychotic Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Antipsychotic Drugs Sales by Manufacturers
3.1.1 Antipsychotic Drugs Sales by Manufacturers 2014-2019
3.1.2 Antipsychotic Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Antipsychotic Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Antipsychotic Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Antipsychotic Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Antipsychotic Drugs Price by Manufacturers
3.4 Key Manufacturers Antipsychotic Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antipsychotic Drugs Market
3.6 Key Manufacturers Antipsychotic Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 First Antipsychotic Drugs Sales and Revenue (2014-2019)
4.1.2 Second Antipsychotic Drugs Sales and Revenue (2014-2019)
4.1.3 Third Antipsychotic Drugs Sales and Revenue (2014-2019)
4.2 Global Antipsychotic Drugs Sales Market Share by Type
4.3 Global Antipsychotic Drugs Revenue Market Share by Type
4.4 Antipsychotic Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antipsychotic Drugs Sales by Application
6 United States
6.1 United States Antipsychotic Drugs Breakdown Data by Company
6.2 United States Antipsychotic Drugs Breakdown Data by Type
6.3 United States Antipsychotic Drugs Breakdown Data by Application
7 European Union
7.1 European Union Antipsychotic Drugs Breakdown Data by Company
7.2 European Union Antipsychotic Drugs Breakdown Data by Type
7.3 European Union Antipsychotic Drugs Breakdown Data by Application
8 China
8.1 China Antipsychotic Drugs Breakdown Data by Company
8.2 China Antipsychotic Drugs Breakdown Data by Type
8.3 China Antipsychotic Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Antipsychotic Drugs Breakdown Data by Company
9.2 Rest of World Antipsychotic Drugs Breakdown Data by Type
9.3 Rest of World Antipsychotic Drugs Breakdown Data by Application
9.4 Rest of World Antipsychotic Drugs Breakdown Data by Countries
9.4.1 Rest of World Antipsychotic Drugs Sales by Countries
9.4.2 Rest of World Antipsychotic Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Antipsychotic Drugs
10.1.4 Antipsychotic Drugs Product Introduction
10.1.5 AstraZeneca Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Antipsychotic Drugs
10.2.4 Antipsychotic Drugs Product Introduction
10.2.5 Eli Lilly Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Antipsychotic Drugs
10.3.4 Antipsychotic Drugs Product Introduction
10.3.5 GlaxoSmithKline Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Antipsychotic Drugs
10.4.4 Antipsychotic Drugs Product Introduction
10.4.5 Johnson & Johnson Recent Development
10.5 Actavis Generics
10.5.1 Actavis Generics Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Antipsychotic Drugs
10.5.4 Antipsychotic Drugs Product Introduction
10.5.5 Actavis Generics Recent Development
10.6 Alkermes
10.6.1 Alkermes Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Antipsychotic Drugs
10.6.4 Antipsychotic Drugs Product Introduction
10.6.5 Alkermes Recent Development
10.7 Bristol-Myers Squibb
10.7.1 Bristol-Myers Squibb Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Antipsychotic Drugs
10.7.4 Antipsychotic Drugs Product Introduction
10.7.5 Bristol-Myers Squibb Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antipsychotic Drugs Sales Channels
11.2.2 Antipsychotic Drugs Distributors
11.3 Antipsychotic Drugs Customers
12 Market Forecast
12.1 Global Antipsychotic Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Antipsychotic Drugs Sales Forecast by Type
12.3 Global Antipsychotic Drugs Sales Forecast by Application
12.4 Antipsychotic Drugs Forecast by Regions
12.4.1 Global Antipsychotic Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Antipsychotic Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Antipsychotic Drugs Product Picture
Table Antipsychotic Drugs Key Market Segments
Table Major Manufacturers Antipsychotic Drugs Covered in This Report
Table Global Antipsychotic Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Antipsychotic Drugs Sales Market Shar by Type 2014-2025
Figure First Antipsychotic Drugs Figures
Table Major Manufacturers of First Antipsychotic Drugs
Figure Second Antipsychotic Drugs Figures
Table Major Manufacturers of Second Antipsychotic Drugs
Figure Third Antipsychotic Drugs Figures
Table Major Manufacturers of Third Antipsychotic Drugs
Table Global Antipsychotic Drugs Market Share by Application 2019-2025 (K Units)
Figure Schizophrenia Use Case
Figure Bipolar Disorder Use Case
Figure Unipolar Depression Use Case
Figure Dementia Use Case
Figure Others Use Case
Figure Antipsychotic Drugs Report Years Considered
Figure Global Antipsychotic Drugs Market Size 2014-2025 (Million US$)
Figure Global Antipsychotic Drugs Sales 2014-2019 (K Units)
Table Global Antipsychotic Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Antipsychotic Drugs Sales by Regions 2014-2019 (K Units)
Table Global Antipsychotic Drugs Sales Market Share by Regions 2014-2019
Figure Global Antipsychotic Drugs Sales Market Share by Regions 2014-2019
Figure Global Antipsychotic Drugs Sales Market Share by Regions in 2019
Table Global Antipsychotic Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Antipsychotic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Antipsychotic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Antipsychotic Drugs Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Antipsychotic Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Antipsychotic Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Antipsychotic Drugs Sales Share by Manufacturers in 2019
Table Antipsychotic Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Antipsychotic Drugs Revenue Share by Manufacturers (2014-2019)
Figure Antipsychotic Drugs Value Share by Manufacturers in 2019
Table Global Antipsychotic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Antipsychotic Drugs Price (2014-2019) (USD/Unit)
Table Key Manufacturers Antipsychotic Drugs Plants/Factories Distribution
Table Key Manufacturers Antipsychotic Drugs Area Served
Table Date of Key Manufacturers Enter into Antipsychotic Drugs Market
Table Key Manufacturers Antipsychotic Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global First Antipsychotic Drugs Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Second Antipsychotic Drugs Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Third Antipsychotic Drugs Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Antipsychotic Drugs Sales by Type (2014-2019) (K Units)
Table Global Antipsychotic Drugs Sales Share by Type (2014-2019)
Figure Global Antipsychotic Drugs Sales Market Share by Type (2014-2019)
Figure Global Antipsychotic Drugs Sales Market Share by Type in 2018
Table Global Antipsychotic Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Antipsychotic Drugs Revenue Share by Type (2014-2019)
Figure Global Antipsychotic Drugs Revenue Market Share by Type (2014-2019)
Figure Global Antipsychotic Drugs Revenue Market Share by Type in 2018
Table Antipsychotic Drugs Price by Type 2014-2019 (USD/Unit)
Table Global Antipsychotic Drugs Sales by Application (2014-2019) (K Units)
Table Global Antipsychotic Drugs Sales Share by Application (2014-2019)
Figure Global Sales Antipsychotic Drugs Market Share by Application (2014-2019)
Figure Global Sales Antipsychotic Drugs Market Share by Application (2014-2019)
Figure United States Antipsychotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure United States Antipsychotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table United States Antipsychotic Drugs Sales by Company (2014-2019) (K Units)
Table United States Antipsychotic Drugs Sales Market Share by Company (2014-2019)
Figure United States Antipsychotic Drugs Sales Market Share by Company in 2019
Table United States Antipsychotic Drugs Sales by Type (2014-2019) (K Units)
Table United States Antipsychotic Drugs Sales Market Share by Type (2014-2019)
Figure United States Antipsychotic Drugs Market Share by Type in 2019
Table United States Antipsychotic Drugs Sales by Application (2014-2019) (K Units)
Table United States Antipsychotic Drugs Sales Market Share by Application (2014-2019)
Figure United States Antipsychotic Drugs Market Share by Application in 2019
Figure European Union Antipsychotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure European Union Antipsychotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Antipsychotic Drugs Sales by Company (2014-2019) (K Units)
Table European Union Antipsychotic Drugs Sales Market Share by Company (2014-2019)
Figure European Union Antipsychotic Drugs Sales Market Share by Company in 2019
Table European Union Antipsychotic Drugs Sales by Type (2014-2019) (K Units)
Table European Union Antipsychotic Drugs Sales Market Share by Type (2014-2019)
Figure 2018 European Union Antipsychotic Drugs Market Share by Type
Table European Union Antipsychotic Drugs Sales by Application (2014-2019) (K Units)
Table European Union Antipsychotic Drugs Sales Market Share by Application (2014-2019)
Figure 2018 European Union Antipsychotic Drugs Market Share by Application
Figure China Antipsychotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure China Antipsychotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table China Antipsychotic Drugs Sales by Company (2014-2019) (K Units)
Table China Antipsychotic Drugs Sales Market Share by Company (2014-2019)
Figure China Antipsychotic Drugs Sales Market Share by Company in 2019
Table China Antipsychotic Drugs Sales by Type (2014-2019) (K Units)
Table China Antipsychotic Drugs Sales Market Share by Type (2014-2019)
Figure China Antipsychotic Drugs Market Share by Type in 2019
Table China Antipsychotic Drugs Sales by Application (2014-2019) (K Units)
Table China Antipsychotic Drugs Sales Market Share by Application (2014-2019)
Figure China Antipsychotic Drugs Market Share by Application in 2019
Figure Rest of World Antipsychotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Antipsychotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Antipsychotic Drugs Sales by Company (2014-2019) (K Units)
Table Rest of World Antipsychotic Drugs Sales Market Share by Company (2014-2019)
Figure Rest of World Antipsychotic Drugs Sales Market Share by Company in 2019
Table Rest of World Antipsychotic Drugs Sales by Type (2014-2019) (K Units)
Table Rest of World Antipsychotic Drugs Sales Market Share by Type (2014-2019)
Figure Rest of World Antipsychotic Drugs Market Share by Type in 2019
Table Rest of World Antipsychotic Drugs Sales by Application (2014-2019) (K Units)
Table Rest of World Antipsychotic Drugs Sales Market Share by Application (2014-2019)
Figure Rest of World Antipsychotic Drugs Market Share by Application in 2019
Table Rest of World Antipsychotic Drugs Sales by Countries (2014-2019) (K Units)
Table Rest of World Antipsychotic Drugs Sales Market Share by Countries (2014-2019)
Figure Rest of World Antipsychotic Drugs Sales Market Share by Countries in 2019
Table Rest of World Antipsychotic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Antipsychotic Drugs Revenue Market Share by Countries (2014-2019)
Figure Rest of World Antipsychotic Drugs Revenue Market Share by Countries in 2019
Figure Japan Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Antipsychotic Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Antipsychotic Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure India Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Antipsychotic Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Antipsychotic Drugs Revenue Growth Rate (2014-2019) (K Units)
Table AstraZeneca Company Details
Table AstraZeneca Description and Business Overview
Table AstraZeneca Antipsychotic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Antipsychotic Drugs Sales Growth Rate (2014-2019)
Table AstraZeneca Antipsychotic Drugs Sales Market Share in Global Market
Table AstraZeneca Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Description and Business Overview
Table Eli Lilly Antipsychotic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Antipsychotic Drugs Sales Growth Rate (2014-2019)
Table Eli Lilly Antipsychotic Drugs Sales Market Share in Global Market
Table Eli Lilly Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Antipsychotic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Antipsychotic Drugs Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Antipsychotic Drugs Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Antipsychotic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Antipsychotic Drugs Sales Growth Rate (2014-2019)
Table Johnson & Johnson Antipsychotic Drugs Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Table Actavis Generics Company Details
Table Actavis Generics Description and Business Overview
Table Actavis Generics Antipsychotic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Actavis Generics Antipsychotic Drugs Sales Growth Rate (2014-2019)
Table Actavis Generics Antipsychotic Drugs Sales Market Share in Global Market
Table Actavis Generics Recent Development
Table Alkermes Company Details
Table Alkermes Description and Business Overview
Table Alkermes Antipsychotic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alkermes Antipsychotic Drugs Sales Growth Rate (2014-2019)
Table Alkermes Antipsychotic Drugs Sales Market Share in Global Market
Table Alkermes Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Description and Business Overview
Table Bristol-Myers Squibb Antipsychotic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Antipsychotic Drugs Sales Growth Rate (2014-2019)
Table Bristol-Myers Squibb Antipsychotic Drugs Sales Market Share in Global Market
Table Bristol-Myers Squibb Recent Development
Figure Antipsychotic Drugs Value Chain
Table Antipsychotic Drugs Distributors List
Table Antipsychotic Drugs Customers List
Table Global Antipsychotic Drugs Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Antipsychotic Drugs Sales Forecast 2019-2025 (K Units)
Figure Global Antipsychotic Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Antipsychotic Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Antipsychotic Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Antipsychotic Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Antipsychotic Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Antipsychotic Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Antipsychotic Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Antipsychotic Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Antipsychotic Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Antipsychotic Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Antipsychotic Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Antipsychotic Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Antipsychotic Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure United States Antipsychotic Drugs Sales Forecast 2019-2025 (K Units)
Figure United States Antipsychotic Drugs Revenue Forecast 2019-2025 (Million US$)
Figure European Union Antipsychotic Drugs Sales Forecast 2019-2025 (K Units)
Figure European Union Antipsychotic Drugs Revenue Forecast 2019-2025 (Million US$)
Figure China Antipsychotic Drugs Sales Forecast 2019-2025 (K Units)
Figure China Antipsychotic Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Japan Antipsychotic Drugs Sales Forecast 2019-2025 (K Units)
Figure Japan Antipsychotic Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Korea Antipsychotic Drugs Sales Forecast 2019-2025 (K Units)
Figure Korea Antipsychotic Drugs Revenue Forecast 2019-2025 (Million US$)
Figure India Antipsychotic Drugs Sales Forecast 2019-2025 (K Units)
Figure India Antipsychotic Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Antipsychotic Drugs Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Antipsychotic Drugs Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Narcolepsy Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80
    According to our LPI (LP Information) latest study, the global Narcolepsy Drug market size was valued at US$ 2715.1 million in 2023. With growing demand in downstream market, the Narcolepsy Drug is forecast to a readjusted size of US$ 5598.9 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Narcolepsy Drug market. Narcolepsy Drug are expected to show stable growth in the future market. However, product differentia......
  • Global Epilepsy Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Epilepsy Drugs market: According to our latest research, the global Epilepsy Drugs market looks promising in the next 5 years. As of 2022, the global Epilepsy Drugs market was estimated at USD 4815.92 million, and it's anticipated to reach USD 6053.85 million in 2028, with a CAGR of 3.89% during the forecast years. Anti-epileptic drugs can eliminate or reduce seizures in two ways. One is to affect central neurons to prevent or reduce their pathologic......
  • Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Drug market size was valued at US$ 46 million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Drug is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Neuromyelitis Optica Drug market. Neuromyelitis Optica Drug are expected to show stable growth in the future marke......
  • Migraine Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118
    The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
  • Global Neuromyelitis Optica Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Neuromyelitis Optica Drug market: According to our latest research, the global Neuromyelitis Optica Drug market looks promising in the next 5 years. As of 2022, the global Neuromyelitis Optica Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Narcolepsy Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Narcolepsy Drug market: According to our latest research, the global Narcolepsy Drug market looks promising in the next 5 years. As of 2022, the global Narcolepsy Drug market was estimated at USD 2915.59 million, and it's anticipated to reach USD 5983.81 million in 2028, with a CAGR of 12.73% during the forecast years. Narcolepsy is a neurological disorder characterized by the brain's inability to control sleep/wakefulness cycles. This......
  • Global Edaravone Market Research Report 2023
    Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 88
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Edaravone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Mitsubishi Tanabe Pharma - Simcere - Taj Pharmaceuticals Ltd. - Sun Pharmaceutical Industries Ltd. - Unichem Laboratories Ltd - UCB India Ltd - Piram......
  • Global Ethoxyquin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Ethoxyquin market: According to our latest research, the global Ethoxyquin market looks promising in the next 5 years. As of 2022, the global Ethoxyquin market was estimated at USD 216.07 million, and it's anticipated to reach USD 303.42 million in 2028, with a CAGR of 5.82% during the forecast years. Ethoxyquin (EQ) is a clear, viscous, light yellow to dark brown liquid, with an unpleasant, mercaptan-like smell, that causes irritation of the skin an......
  • Global Antipsychotic Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Antipsychotic Drugs market: According to our latest research, the global Antipsychotic Drugs market looks promising in the next 5 years. As of 2022, the global Antipsychotic Drugs market was estimated at USD 15363.6 million, and it's anticipated to reach USD 23658.8 million in 2028, with a CAGR of 7.46% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global An......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs